logo
Select company
Select metric
$ -85.36MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
9
Sector
22
Industry
33
History
10
$ 45.71Close
$ 10.8 - $ 80.04 52-Week Range
Ticker Information

Ticker

KRRO

Company Name

KORRO BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KORRO BIO INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KRRO - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 5.9M$ -91.26M$ -85.36M
3/31/2025$ 6.33M$ -87.29M$ -80.95M
12/31/2024$ 6.88M$ -83.44M$ -76.56M
9/30/2024$ 8.9M$ -100.53M$ -91.62M
6/30/2024$ 8.24M$ -91.59M$ -83.34M
3/31/2024$ 7.54M$ -80.93M$ -73.39M
12/31/2023$ 7.24M$ -81.14M$ -73.91M
9/30/2023$ 5.06M$ -60.46M$ -55.4M
6/30/2023$ 5.22M$ -68.05M$ -62.84M
3/31/2023$ 5.45M$ -78.42M$ -72.97M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KORRO BIO INC's latest trailing twelve months (TTM) EBITDA stands at $ -22.38M.
  • Over the past 5 years, KORRO BIO INC's average EBITDA has been $ -68.65M.
  • The median EBITDA for KORRO BIO INC during this period was $ -75.23M
  • KORRO BIO INC reached its highest EBITDA over the past 5 years at $ -22.38M.
  • The lowest EBITDA recorded by KORRO BIO INC in the same timeframe $ -91.62M

KORRO BIO INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
CRBU : CARIBOU BIOSCIENCES INC $ -157.49MACOG : ALPHA COGNITION INC $ -19.86MTCRX : TSCAN THERAPEUTICS INC $ -130.55MTVRD : TVARDI THERAPEUTICS INC $ -13.45MOBIO : ORCHESTRA BIOMED HOLDINGS INC $ -68.61MFATE : FATE THERAPEUTICS INC $ -155.49MCRVO : CERVOMED INC $ -22.61MOVID : OVID THERAPEUTICS INC $ -36.47MCBUS : CIBUS INC $ -234.61MARMP : ARMATA PHARMACEUTICALS INC $ -10.66M

Similar metrics to EBITDA:

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA EBITDA for KORRO BIO INC is calculated as follows: EBIT [ $ -23.62M ] + DepAmor [ $ 1.24M ]
(=) EBITDA [ $ -22.38M ]

KRRO - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -91.62M

Minimum

Sep 30, 2024

$ -22.38M

Maximum

Sep 30, 2020

$ -68.65M

Average

$ -75.23M

Median

EBITDA Benchmark Analysis

 The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.76M with a standard deviation of $ 167.31M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.24K
min$ -494.95M
max$ 590.6M
average$ 58.76M
median$ 8.92M
std$ 167.31M